|
Through subsidiaries and affiliated companies in about 50 countries, the Belgium-based Solvay operates, for the time being, in three sectors: plastics, chemicals, and pharmaceuticals. Its plastics compounds include vinyl and polyethylene products; it also processes plastics into pipe, waterproofing foils, and fuel and air intake systems for automobiles. The chemicals sector makes hydrogen peroxide and soda ash (used to make glass). And Solvay's pharmaceuticals include cardiological drugs, gastrointestinal enzymes, and antidepressants. However, it agreed to sell that last unit to Abbott Labs in 2009 for about E5.2 billion ($7.6 billion US). Belgian holding company Solvac owns more than 30% of Solvay.
|
| | | Contact Information | |
Address: |
Rue du Prince Albert, 33
B-1050 Brussels, Belgium
| | Phone: | +32-2-509-61-11 | | Fax: | +32-2-509-66-17 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 13376.20 M | | Revenue Growth (1 yr): | (-5.10%) | | Employees (2007): | 28,340 | | Employee Growth (1 yr): | (-3.10%) |
|
|
Key People
| | • |
Chairman:
Aloïs Michielsen
| | • |
CEO and Director:
Christian Jourquin
| | • |
CFO and Director:
Bernard de Laguiche
|
|
|
